LadRx Competitors and Similar CompaniesClear all
LadRx's competitors and similar companies include ImmunoMet and Fennec Pharma.
 LadRx LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. |  ImmunoMet ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism. |  Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. | |
Founding Date | Founding Date 1985 | Founding Date 2015 | Founding Date 1996 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Los Angeles, US HQ | Locations Houston, US HQ | Locations US HQ |
Employees | Employees 385% decrease | Employees 814% increase | Employees 433% increase |
Valuation ($) | Valuation ($) 901.1 k | Valuation ($) N/A | Valuation ($) 129.4 m |
Financial | |||
Net income | Net income ($1.6m) (FY, 2024) | Net income N/A | Net income ($9.7m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
ImmunoMet
HQ
Houston, US
Employees
8↑ 14% increase
ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism.
View companyFennec Pharma
HQ
US
Employees
4↑ 33% increase
Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.
View company